QA: Alimera Sciences INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2017_Alimera_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}

Graph

Absolute values for 0001267602, Alimera Sciences INC

  xvar xval
0 AssetsCurrent 47,402,000
1 IntangibleAssetsNetIncludingGoodwill 20,604,000
2 PropertyPlantAndEquipmentNet 1,787,000
3 remainder_Assets 436,000
4 LiabilitiesCurrent 9,123,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,765,546
9 ResearchAndDevelopmentExpense 12,004,187
10 remainder_Expenses 40,256,374
11 remainder_Revenues 93,725,982
12 remainder_NetIncome 4,147,078
13 remainder_ComprehensiveNetIncome -175,418
  yvar yval
0 Assets 70,229,000
1 Liabilities 9,123,000
2 Expenses 68,026,107
3 Revenues 93,725,982
4 StockholdersEquity 61,106,000
5 NetIncome 29,846,953
6 ComprehensiveNetIncome 29,759,244
7 BaseVar 122,713,292
8 EconomicCapitalRatiobeforeLimitedLiability 4.11
9 EconomicCapitalRatio 4.47

Edgar->Model Mapping

Feature Distribution

Change over Time